A patient has been prescribed sitagliptin for the treatment of type 2 diabetes. Which of the following is an added benefit to the use of this medication?


•Sitagliptin (Januvia) is a dipeptidyl peptidase-4 inhibitor. It increases insulin secretion and contributes to less weight gain than other oral antihyperglycemics.

•Incorrect: Sitagliptin does not lower blood pressure or improve symptoms of GERD or BPH.

Visit our website for other NCLEX topics now!